4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0001209191-21-054292
Director sold 936 shares at an average $91.29 ($85,449)
- Director acquired 936 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BOLGER JOHN C · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-30 | Exercise or conversion : show line 1 in the form | +312 | $3.93 | $1,225 | 2,312 | D |
| 2021-08-30 | Sale : show line 2 in the form | −312 | $91.38 | $28,511 | 2,000 | D |
| 2021-08-30 | Exercise or conversion : show line 3 in the form | +312 | $15.82 | $4,936 | 2,312 | D |
| 2021-08-30 | Sale : show line 4 in the form | −312 | $91.05 | $28,409 | 2,000 | D |
| 2021-08-30 | Exercise or conversion : show line 5 in the form | +312 | $5.81 | $1,813 | 2,312 | D |
| 2021-08-30 | Sale : show line 6 in the form | −312 | $91.44 | $28,530 | 2,000 | D |
| Open-market sales · 936 sh · avg $91.29 · $85,449 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-30 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −312 | 938 | D |
| 2021-08-30 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −312 | 2,188 | D |
| 2021-08-30 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −312 | 3,438 | D |
Loading xslF345X03/doc4.xml…